NYSE AmericanUSD
OS Therapies Incorporated
$.+0.6%
52w low $1.15$2.25 52w high
Market data
- 52w range
- $1.15 - $2.25
- Sector
- Unknown
About OS Therapies Incorporated
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.
Valuation
Overall Rating
0
Not rated
Moat Score0
Fair value estimate
Not covered by our valuation model yet.
Moat, fair value and rating computed by our valuation engine (ported from the original Python model).
Fundamentals
Market Cap
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
0.0%
Profit Margin
0.0%
ROE
0.0%
Debt / Equity
0.00
Beta
0.00